Bottom line
GQLVX vs REVS: the short answer
GQLVX (Disciplined U.S. Value Equity Portfolio) and REVS (Columbia Research Enhanced Value ETF) are quite different portfolios: only about 20% of their top holdings (by weight) are shared.
But REVS is far broader, holding 307 positions to 85 for GQLVX, so beyond the top names it adds exposure GQLVX doesn't have.
REVS is cheaper at 0.19% vs 0.85% — a difference of $66 a year per $10,000 invested.
Over five years, REVS returned +13.2% a year vs +11.1% for GQLVX.
Updated Nov 19, 2026
GQLVX vs REVS side by side
| GQLVX | REVS | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Glenmede | Columbia Threadneedle |
| Category | Large Value | Large Value |
| Expense ratio | 0.85% | 0.19% |
| Annual cost per $10k | $85 | $19 |
| 10-yr cost on $10k (prospectus) | $3,581 | $254 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +15.0% | +16.6% |
| 5-yr return (annualized) | +11.1% | +13.2% |
| 10-yr return (annualized) | — | — |
| Best quarter | +18.5% | +15.1% |
| Worst quarter | −32.1% | −26.3% |
| Net assets (fund) | $2.7M | $333.7M |
| Number of holdings | 85 | 307 |
| Portfolio turnover | 86% | 69% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GQLVX | REVS | Difference |
|---|---|---|---|
| 2025 | +15.0% | +16.6% | −1.6% |
| 2024 | +11.5% | +16.4% | −4.8% |
| 2023 | +9.2% | +13.2% | −4.1% |
| 2022 | −6.3% | −5.8% | −0.5% |
| 2021 | +29.3% | +28.4% | +0.9% |
| 2020 | −1.8% | +1.5% | −3.2% |
Source: Fund prospectus bar charts
Holdings overlap
7 of GQLVX's top 25 holdings also appear in REVS's top 25.
| Holding | GQLVX | REVS |
|---|---|---|
| Bristol-Myers Squibb Co | 2.47% | 1.79% |
| US Bancorp | 2.41% | 0.97% |
| Cisco Systems Inc | 2.38% | 1.70% |
| CVS Health Corp | 2.18% | 1.68% |
| General Dynamics Corp | 2.10% | 1.04% |
| Altria Group Inc | 1.77% | 2.22% |
| Newmont Corp | 1.49% | 1.07% |
Source: SEC Form N-PORT
GQLVX top 10
- Hewlett Packard Enterprise Co — 2.97%
- TechnipFMC PLC — 2.50%
- Bristol-Myers Squibb Co — 2.47%
- Cognizant Technology Solutions Corp — 2.44%
- Regeneron Pharmaceuticals Inc — 2.42%
- US Bancorp — 2.41%
- Cisco Systems Inc — 2.38%
- eBay Inc — 2.38%
- HP Inc — 2.20%
- CVS Health Corp — 2.18%
REVS top 10
- Apple Inc — 8.00%
- Microsoft Corp — 6.81%
- Bank of America Corp — 3.85%
- Chevron Corp — 2.73%
- Altria Group Inc — 2.22%
- Citigroup Inc — 1.90%
- Meta Platforms Inc — 1.79%
- Bristol-Myers Squibb Co — 1.79%
- TJX Cos Inc/The — 1.73%
- Cisco Systems Inc — 1.70%
FAQ
What is the difference between GQLVX and REVS?
Which is cheaper, GQLVX or REVS?
Should I own both GQLVX and REVS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.